Previous Article | Next Article ![]()
Molecular and Cellular Biology, May 2004, p. 4571-4580, Vol. 24, No. 10
0270-7306/04/$08.00+0 DOI: 10.1128/MCB.24.10.4571-4580.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9039
Received 22 October 2003/ Returned for modification 3 December 2003/ Accepted 24 February 2004
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Human germ line telomeres contain 15- to 20-kb-long tracks of repetitive TTAGGG hexamers (21), ending with the G-rich strand forming a 3' single-stranded overhang (19). This overhang can invade the more-proximal duplex telomeric repeats to form a lariat-like structure called a t-loop (telomere loop) that may be involved in preventing the end of the chromosome from being recognized as a double-strand break needing repair (13).
In addition to providing a solution to the inability of lagging-strand DNA synthesis to replicate the very 3' end of linear molecules and hiding the ends from the double-strand break recognition system, telomeres also anchor the chromosomal ends to the nuclear matrix and serve as sites of chromosome alignment during meiosis (7, 27). This latter function, facilitating alignment at the ends of the chromosomes, may provide a partial explanation for the increased density of genes near chromosome ends and the increased frequency of meiotic recombination in that region (reviewed in reference 20). In contrast to the increased recombination on a megabase scale near telomeres that is observed in this gene-rich region, there is a more-proximate inhibition of recombination manifested by a dramatic linkage disequilibrium that can, in some cases, extend 100 kb beyond the base of the telomere (reviewed in reference 20). For example, there are three predominant haplotypes for the subtelomeric region of chromosome 16p that can differ in size by 260 kb (5, 30). This inhibition of recombination has been analyzed at the level of single-nucleotide polymorphisms for chromosome 12q. Over 20 single-nucleotide polymorphisms within the largely identical 2-kb region next to the telomere segregate into only three predominant haplotypes in Caucasians (2). This linkage disequilibrium within the nonrepetitive subtelomeric sequences extends into the repetitive region as well. Variants of the sequence TTAGGG (such as TGAGGG) are present at the very base of the telomeres, presumably because this region is so far from the ends that it is not regenerated by telomerase in the germ line (1). Remarkably specific patterns of sequence variants are maintained within this repetitive region among the 12q haplotypes (2). Specific repetitive variant haplotypes have also been demonstrated on chromosome 16p and the Xp/Yp autosomal region as well (5). The barrier to recombination at telomeres prevents recombination from being used to maintain telomere length under normal circumstances, and it is only found as an alternative to telomerase in a small fraction of immortal cells (4).
DNA base modifications such as methylation are used by many organisms to protect themselves from viral parasites, not only to repress transcription but also to inhibit illegitimate recombination between sequences integrated at different locations. This is thought to be the evolutionary reason why various repetitive elements are methylated in the mammalian genome (reviewed in reference 33). The extremely repetitive nature of telomeres, the normal lack of recombination as a length maintenance mechanism, and the linkage disequilibrium including subtelomeric regions suggest the possibility of extensive base modifications at telomeres. Although unusual base modifications have been described at trypanosome telomeres (29), no such modifications have yet been reported in human telomeres. The best evidence to date suggesting the presence of extensive subtelomeric DNA modifications is the proposed existence of an approximately 2- to 4-kb region of subtelomeric DNA that is resistant to enzymatic digestion (18) and thus contributes to the apparent size of telomeres on gels. This prediction is based on the rate of decrease of telomeric probe signals with size that results in a disappearance of signal when telomeres are still 2 to 4 kb in size (6). This calculation has been confirmed by a comparison of in situ hybridization signals to telomeres in metaphase chromosomes and telomere sizes as determined on gels (16). The published distribution of variant sequences at the base of chromosomes 12p, 16p, and Xp/Yp (that would not hybridize to the canonical TTAGGG probes) suggests that they might contribute less than 500 bp to the X-region, leaving the cause of the remainder undetermined.
Here we show that known restriction sites within the subtelomeric DNA are resistant to digestion with different types of restriction enzymes, and the extent of this resistance varies with telomere length. Comparing the digestion using methylation-resistant versus -sensitive restriction enzymes excludes a major or exclusive role for 5-methylcytidine and suggests that other nucleotide modifications are present near human telomeres.
| MATERIALS AND METHODS |
|---|
|
|
|---|
TRF analysis. Mean telomere length was evaluated by using TRF analysis, a variation of standard Southern analysis. DNAs isolated from different cell clones were digested with either NlaIII, MboI, Sau3A, or a mixture of six enzymes (AluI, CfoI, HaeIII, HinfI, MspI, RsaI) and resolved on a 0.7% agarose gel. The denatured and dried gel was hybridized with 32P-labeled oligonucleotides [(TTAGGG)4] and exposed to a PhosphorImager screen, and the weighted mean telomere length was calculated as described previously (23).
Southern blotting. Genomic DNA (20 µg) was digested with restriction enzymes and separated on a 0.8% agarose gel. After denaturing the gel, the DNA was transferred onto a positively charges nylon membrane (Zetaprobe; Bio-Rad) using capillary transfer followed by UV fixation. The membrane was hybridized with a specific probe labeled with a random primed labeling kit (Invitrogen) using the manufacturer's protocol.
Telomere preparation and ligation to primers. Telomeres were purified from 100 µg of genomic DNA digested with NlaIII or SphI as described previously (32). In brief, a biotinylated oligonucleotide, (CCCTAA)6, was annealed to the G-rich overhang of telomeres in 1x SSC (0.15 M NaCl plus 0.015 M sodium citrate) and recovered with streptavidin-coated micro beads (Miltenyi Biotec) using MiniMACS separation columns (Miltenyi Biotec). The telomeres were released into 200 µl of Tris-EDTA at 65°C and redigested to ensure complete digestion of all available recognition sites (using approximately 10 U of enzyme for a few nanograms of purified telomeres). The last digested restriction site remaining attached to the telomere was tagged by ligation to a double-stranded biotinylated linker, SA (5'-biotinyl-TTTGGATTTGCTGGTGCAGTACAACTAGGCTTAATAGGGACATG-3' annealed to 5'-TCCCTATTAAGCCTAGTTGTACTGCACCAGCAAATCC-3'), having an overhang compatible with NlaIII and SphI sites. A 0.5-pmol aliquot was ligated to 100 µl of the telomere preparation at 16°C overnight using 5 U of T4 ligase (Roche). The ligated telomeres were then repurified using 0.8% agarose gels. After the 2-kb size marker had migrated about 4 cm, the gel was cut at 2 kb and everything below that size marker was discarded. The electrodes were then reversed, and the DNA was back-migrated until the ethidium bromide-stained molecular weight standard had returned to the origin. To ensure a constant and reproducible rate of back-migration, the lower part of the gel that was removed was replaced with fresh 0.8% agarose and the slots at the origin were replaced with 1% low-melting-point agarose. Streptavidin-coated beads (Dynal) were used to recover biotinylated linker-telomere complexes out of the gelase-treated (Epigenetics) low-melting-point agarose blocks. After washing with Tris-EDTA-0.05% Triton, aliquots of the telomere-bead complexes were added directly to PCRs.
PCR analysis of subtelomeres. The subtelomeric fraction that stays attached to the telomere after digestion with restriction enzymes was determined using PCR with the following primers (see Fig. 4 and 5, below, for primer locations): XpYpE2F, 5'-TTGTCTCAGGGTCCTAGTG-3'; XpYpB2, 5'-TCTGAAAGTGGACCTATCAG-3'; XpYpE2R, 5'-CACTAGGACCCTGAGACAA-3'; XpYp2NR, 5'-TCTCGGGAGTCCCCGTCTAT-3'; XpYp4NR, 5'-GATATGGCCCACTCAGGCAC-3'; XpYp8NR, 5'-GAACATAGAATTGGAAAACGCG-3'; SA, 5'-GGATTTGCTGGTGCAGTACA-3'. Telomeres from HeLa cells containing a luciferase gene immediately adjacent to a newly seeded telomere were amplified with LucF (5'-AGATGCACATATCGAGGTGAAC-3'), LucR (5'-CATACTGTTGAGCAATTCAC-3') (annealing temperature, 50°C), PolyAF (5'-GATCGTGGATTACGTCGCC-3'), and PolyAR (5'-CTTGTTTATTGCAGCTTATAATGG-3') (annealing temperature, 50°C). Sequence analysis revealed a nucleotide polymorphism generating an additional NlaIII site at position bp 1712 (in HUMTARS7AL; gi338679) in our HeLa cells compared to the published sequence. The following primers telomere proximal from this site were used to amplify the Xp/Yp region from this HeLa-derived cell clone to measure the abundance of total telomeric DNA in the different preparations, XpYpHF (5'-TGAAGCTGCAGACCTTTGCG-3') and XpYpB2 (5'-TCTGAAAGTGGACCTATCAG-3'). All amplifications were performed using a GeneAmp PCR System 9700 (PE Applied Biosystems) running a profile of 35 cycles of 95°C for 20 s, 55°C (if not otherwise noted) for 20 s, and 72°C for 40 s. We used 1 U of HotStar Taq polymerase (Qiagen), 200 µM deoxynucleoside triphosphates, and 0.1 µM primer in PCR buffer (provided by the manufacturer; containing 1.5 mM MgCl2) per 50-µl reaction mix.
|
|
| RESULTS |
|---|
|
|
|---|
|
|
|
These results with an artificial healed telomere in a tumor cell line were confirmed for the Xp/Yp telomeres in normal diploid BJ fibroblasts. DNA from three BJ derivatives with different telomere lengths (the same as shown in Fig. 2) was digested with NlaIII and purified based upon the presence of G-rich overhangs. After redigesting the DNA, the PCR linker SA was ligated to the exposed NlaIII sites. The telomeres were then repurified as mentioned above. The ligated SA linker marked the most-telomere-proximal NlaIII site that could be digested while still remaining attached to the telomere. It served as the forward primer for a series of PCRs. Under the conditions of PCR used in this study, amplicons longer than 600 bp failed to amplify in the presence of coamplified shorter fragments 100 to 200 bp long. In order to avoid bias due to the preferential amplification of small PCR products, several different reverse primers were used, as illustrated in the map in Fig. 5a.
The E2F/B2 amplicon is internal to any of the NlaIII sites on chromosome Xp/Yp and documented an approximately equal input for the different DNAs used in this analysis (Fig. 5b). All of the expected PCR fragments could be identified in the different samples. In order to confirm the specificity of the reaction, the PCR fragments were transferred to a nylon membrane and hybridized to a radioactive Xp/Yp probe. The results in Fig. 5c demonstrate that not only were all of the predicted fragments present, but also their abundance varied in proportion to telomere length. For example, the fragment representing the ligation of the SA primer to the ninth NlaIII (9N) site 1.6 kb from the telomere requires that all eight telomere-proximal sites are resistant to NlaIII digestion. The 9N amplicon corresponding to the ninth site was present in BJ cells with 13-kb telomeres but could not be detected in BJ cells with 10- or 6-kb telomeres.
Taken together, these data indicate that the X-region varies with telomere length on one specific telomere analyzed. The generalization of this conclusion to the majority of telomeres was confirmed analyzing the X-region as a function of TRF length for both six-enzyme- and NlaIII-digested DNA. At long telomere lengths, NlaIII yielded slightly larger TRF sizes than the six-enzyme digestion, but this difference disappeared as telomeres became shorter (Fig. 6c and d). The difference between the telomere length determined by TRF and Q-FISH analyses represents the X-region for any given sample. This difference of TRF (kilobases) minus Q-FISH (kilobases) for these enzymes was plotted versus the average Q-FISH values from Fig. 1 (Fig. 6a and b). The slope of the regression lines indicates that the X-region increases by about 0.4 to 0.7 kb per kb of telomere length. In other words, approximately one-third of the rate of TRF shortening in these cells (about 500 bp per 1.5 kb of shortening) is due to a decrease in the X-region rather than a decrease in the actual size of the telomere.
|
| DISCUSSION |
|---|
|
|
|---|
Cytidine methylation is the only known base modification to occur in mammalian DNA (14). It is primarily present in CpG dinucleotides, although some modifications of CpA and CpT have been reported (24). Neither MboI (GATC) nor NlaIII (CATG) are sensitive to cytidine methylation. NlaIII sites are sensitive to adenine methylation in bacterial cells (22, 25), but such modifications have not been observed in mammalian DNA. The thymidine modification beta-D-glucosylhydroxymethyluracil (base J) is present in repetitive sequences, primarily telomeric DNA, of kinetoplastid protozoans such as trypanosomes (10, 11, 29). It is involved in vesicular stomatitis virus gene silencing and produces resistance to enzymatic digestion. Antibodies that detect base J do not react with mammalian DNA (28), so it is unlikely to represent the modification that produces the X-region in human cells. The specific structure preventing enzyme digestion in this region remains to be determined.
The X-region represents the amount of TRF length that is due to telomeric sequence variants at the base of the telomere plus the average distance over which no restriction sites can be digested. The total number of sites that must be modified increases as the distance from the telomere increases, and to be seen as an X-region every single site needs to be modified (to a first approximation, any single unmodified site will be cut). The present data thus address only the distance over which the efficiency of modification is so high that every single telomere-proximal site has been modified, not how far into the subtelomeric DNA potential base modifications can spread.
Telomeres are unique structures in the genome. Blocks of 10 to 15 kb of highly repetitive TTAGGG sequences present in each of 92 different telomeres of a typical young normal human diploid cell would be expected to be enormously recombinogenic in the absence of mechanisms to prevent it. The total absence of both CpG and CpA sequences in the telomeric DNA sequence prevents the use of most of the known mammalian modifications thought to contribute to reduced recombination between repetitive elements, although the presence of CpT sequences makes some telomeric methylation possible. It is possible that the DNA base modifications producing the X-region are a substitute for cytidine methylation and are involved in preventing recombination over telomeres. This would also produce the linkage disequilibrium seen in the immediately subtelomeric region and the unusual pattern of exchanges between telomeres of up to 50 kb into the subtelomeric region (20), and they could contribute to the presence or extent of telomere position effects in mammalian cells. Changes in telomeric DNA modifications might also contribute to the increased recombination seen in alternative lengthening of telomere (ALT) pathway cells.
| ACKNOWLEDGMENTS |
|---|
This work was supported by the National Institutes of Health (AG01228). W.E.W. is an Ellison Medical Foundation Senior Scholar.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
2. Baird, D. M., J. Coleman, Z. H. Rosser, and N. J. Royle. 2000. High levels of sequence polymorphism and linkage disequilibrium at the telomere of 12q: implications for telomere biology and human evolution. Am. J. Hum. Genet. 66:235-250.[CrossRef][Medline]
3. Baur, J. A., Y. Zou, J. W. Shay, and W. E. Wright. 2001. Telomere position effect in human cells. Science 292:2075-2077.
4. Bryan, T. M., L. Marusic, S. Bacchetti, M. Namba, and R. R. Reddel. 1997. The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit. Hum. Mol. Genet. 6:921-926.
5. Coleman, J., D. M. Baird, and N. J. Royle. 1999. The plasticity of human telomeres demonstrated by a hypervariable telomere repeat array that is located on some copies of 16p and 16q. Hum. Mol. Genet. 8:1637-1646.
6. Counter, C. M., A. A. Avilion, C. E. LeFeuvre, N. G. Stewart, C. W. Greider, C. B. Harley, and S. Bacchetti. 1992. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11:1921-1929.[Medline]
7. de Lange, T. 1992. Human telomeres are attached to the nuclear matrix. EMBO J. 11:717-724.[Medline]
8. de Lange, T., L. Shiue, R. M. Myers, D. R. Cox, S. L. Naylor, A. M. Killery, and H. E. Varmus. 1990. Structure and variability of human chromosome ends. Mol. Cell. Biol. 10:518-527.
9. Ferguson, B. M., and W. L. Fangman. 1992. A position effect on the time of replication origin activation in yeast. Cell 68:333-339.[CrossRef][Medline]
10. Gommers-Ampt, J., J. Lutgerink, and P. Borst. 1991. A novel DNA nucleotide in Trypanosoma brucei only present in the mammalian phase of the life-cycle. Nucleic Acids Res. 19:1745-1751.
11. Gommers-Ampt, J. H., F. Van Leeuwen, A. L. de Beer, J. F. Vliegenthart, M. Dizdaroglu, J. A. Kowalak, P. F. Crain, and P. Borst. 1993. ß-D-Glucosyl-hydroxymethyluracil: a novel modified base present in the DNA of the parasitic protozoan T. brucei. Cell 75:1129-1136.[CrossRef][Medline]
12. Gottschling, D. E., O. M. Aparicio, B. L. Billington, and V. A. Zakian. 1990. Position effect at S. cerevisiae telomeres: reversible repression of Pol II transcription. Cell 63:751-762.[CrossRef][Medline]
13. Griffith, J. D., L. Comeau, S. Rosenfield, R. M. Stansel, A. Bianchi, H. Moss, and T. de Lange. 1999. Mammalian telomeres end in a large duplex loop. Cell 97:503-514.[CrossRef][Medline]
14. Gruenbaum, Y., R. Stein, H. Cedar, and A. Razin. 1981. Methylation of CpG sequences in eukaryotic DNA. FEBS Lett. 124:67-71.[CrossRef][Medline]
15. Harley, C. B., A. B. Futcher, and C. W. Greider. 1990. Telomeres shorten during ageing of human fibroblasts. Nature 345:458-460.[CrossRef][Medline]
16. Hultdin, M., E. Gronlund, K. Norrback, E. Eriksson-Lindstrom, T. Just, and G. Roos. 1998. Telomere analysis by fluorescence in situ hybridization and flow cytometry. Nucleic Acids Res. 26:3651-3656.
17. Koering, C. E., A. Pollice, M. P. Zibella, S. Bauwens, A. Puisieux, M. Brunori, C. Brun, L. Martins, L. Sabatier, J. F. Pulitzer, and E. Gilson. 2002. Human telomeric position effect is determined by chromosomal context and telomeric chromatin integrity. EMBO Rep. 3:1055-1061.[CrossRef][Medline]
18. Levy, M. Z., R. C. Allsopp, A. B. Futcher, C. W. Greider, and C. B. Harley. 1992. Telomere end-replication problem and cell aging. J. Mol. Biol. 225:951-960.[CrossRef][Medline]
19. Makarov, V. L., Y. Hirose, and J. P. Langmore. 1997. Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell 88:657-666.[CrossRef][Medline]
20. Mefford, H. C., and B. J. Trask. 2002. The complex structure and dynamic evolution of human subtelomeres. Nat. Rev. Genet. 3:91-102.[CrossRef][Medline]
21. Moyzis, R. K., J. M. Buckingham, L. S. Cram, M. Dani, L. L. Deaven, M. D. Jones, J. Meyne, R. L. Ratliff, and J. R. Wu. 1988. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc. Natl. Acad. Sci. USA 85:6622-6626.
22. Nelson, M., E. Raschke, and M. McClelland. 1993. Effect of site-specific methylation on restriction endonucleases and DNA modification methyltransferases. Nucleic Acids Res. 21:3139-3154.
23. Ouellette, M. M., M. Liao, B. S. Herbert, M. Johnson, S. E. Holt, H. S. Liss, J. W. Shay, and W. E. Wright. 2000. Subsenescent telomere lengths in fibroblasts immortalized by limiting amounts of telomerase. J. Biol. Chem. 275:10072-10076.
24. Ramsahoye, B. H., D. Biniszkiewicz, F. Lyko, V. Clark, A. P. Bird, and R. Jaenisch. 2000. Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Proc. Natl. Acad. Sci. USA 97:5237-5242.
25. Roberts, R. J., and D. Macelis. 1993. REBASErestriction enzymes and methylases. Nucleic Acids Res. 21:3125-3137.
26. Shay, J. W., and S. Bacchetti. 1997. A survey of telomerase activity in human cancer. Eur. J. Cancer 33:787-791.
27. Smilenov, L. B., S. Dhar, and T. K. Pandita. 1999. Altered telomere nuclear matrix interactions and nucleosomal periodicity in ataxia telangiectasia cells before and after ionizing radiation treatment. Mol. Cell. Biol. 19:6963-6971.
28. van Leeuwen, F., M. C. Taylor, A. Mondragon, H. Moreau, W. Gibson, R. Kieft, and P. Borst. 1998. ß-D-Glucosyl-hydroxymethyluracil is a conserved DNA modification in kinetoplastid protozoans and is abundant in their telomeres. Proc. Natl. Acad. Sci. USA 95:2366-2371.
29. van Leeuwen, F., E. R. Wijsman, E. Kuyl-Yeheskiely, G. A. van der Marel, J. H. van Boom, and P. Borst. 1996. The telomeric GGGTTA repeats of Trypanosoma brucei contain the hypermodified base J in both strands. Nucleic Acids Res. 24:2476-2482.
30. Wilkie, A. O., D. R. Higgs, K. A. Rack, V. J. Buckle, N. K. Spurr, N. Fischel-Ghodsian, I. Ceccherini, W. R. Brown, and P. C. Harris. 1991. Stable length polymorphism of up to 260 kb at the tip of the short arm of human chromosome 16. Cell 64:595-606.[CrossRef][Medline]
31. Wright, W. E., and J. W. Shay. 2002. Historical claims and current interpretations of replicative aging. Nat. Biotechnol. 20:682-688.[CrossRef][Medline]
32. Wright, W. E., V. M. Tesmer, K. E. Huffman, S. D. Levene, and J. W. Shay. 1997. Normal human chromosomes have long G-rich telomeric overhangs at one end. Genes Dev. 11:2801-2809.
33. Yoder, J. A., C. P. Walsh, and T. H. Bestor. 1997. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet. 13:335-340.[CrossRef][Medline]
34. Zakian, V. A. 1996. Structure, function, and replication of Saccharomyces cerevisiae telomeres. Annu. Rev. Genet. 30:141-172.[CrossRef][Medline]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|